Givat-Ela, Israel

Limor Monadeev

This inventor holds 1 USPTO granted patent. Top assignee: Innovo Biotechnologies Ltd.. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Limor Monadeev: Innovator in Avian Vaccination

Introduction

Limor Monadeev is a notable inventor based in Givat-Ella, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines for avian species. His work focuses on addressing critical health challenges faced by birds, ensuring their protection against infectious diseases.

Latest Patents

Limor Monadeev holds a patent for a DNA vaccine designed to protect avian species against the infectious bursal disease virus. This innovative vaccine comprises an effective immunizing amount of a vector that includes one or more isolated nucleic acids encoding an infectious bursal disease virus polypeptide, along with a suitable carrier and/or adjuvant. This invention represents a significant advancement in avian health management.

Career Highlights

Limor Monadeev is associated with Innovo Biotechnologies Ltd., where he applies his expertise in biotechnology to develop groundbreaking solutions. His work at the company has positioned him as a key player in the field of avian vaccination.

Collaborations

Limor has collaborated with esteemed colleagues, including Esther Aboud-Pirak and Esther Shaoul. These partnerships have fostered a collaborative environment that enhances the innovation process and contributes to the success of their projects.

Conclusion

Limor Monadeev's contributions to avian health through his innovative vaccine development highlight his role as a leading inventor in biotechnology. His work not only advances scientific knowledge but also plays a crucial role in protecting avian species from infectious diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…